Tufts CSDD Site Experience Survey
The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting a study on investigative site perspectives and burden associated with Direct-to-Patient (DTP) shipment of study treatments and supplies.
Researchers at Tufts CSDD at the Tufts University School of Medicine, in collaboration with Global Clinical Supplies Group (GCSG), a professional organization of global clinical supplies professionals, are conducting an academic survey to increase understanding of investigative site personnel experiences with the shipment of Investigational Products/Study Treatments to trial participants at their homes—also known as Direct-to-Patient (DtP) shipments of study drug. Your feedback is invaluable in helping to identify pain points and improvement areas.
Please take a few minutes to take survey. In appreciation for your participation, the Tufts CSDD research team will share with you a summary of results when the research concludes. Start the survey:
Thank you in advance for your participation in this important research effort!
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025